DekaBank Deutsche Girozentrale - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$454
-35.4%
100,0000.0%0.00%
-50.0%
Q2 2023$703
+15.2%
100,0000.0%0.00%0.0%
Q1 2023$610
-3.0%
100,0000.0%0.00%0.0%
Q4 2022$629
-99.9%
100,0000.0%0.00%
-33.3%
Q3 2022$942,000
-29.3%
100,000
-19.3%
0.00%
-25.0%
Q2 2022$1,333,000
-35.6%
123,9000.0%0.00%
-20.0%
Q1 2022$2,069,000
-4.7%
123,900
+10.0%
0.01%0.0%
Q4 2021$2,171,000
-28.9%
112,600
-11.8%
0.01%
-44.4%
Q3 2021$3,055,000
-8.6%
127,6000.0%0.01%
-10.0%
Q2 2021$3,343,000
+77.5%
127,600
+100.6%
0.01%
+66.7%
Q1 2021$1,883,000
-38.3%
63,6000.0%0.01%
-45.5%
Q4 2020$3,054,000
+241.6%
63,600
+128.8%
0.01%
+175.0%
Q3 2020$894,000
-63.7%
27,800
-74.5%
0.00%
-66.7%
Q2 2019$2,462,000
+54.9%
109,000
+21.1%
0.01%
+33.3%
Q1 2019$1,589,000
+451.7%
90,000
+176.9%
0.01%
+350.0%
Q4 2018$288,000
-81.9%
32,500
-63.9%
0.00%
-77.8%
Q3 2018$1,589,000
+32.7%
90,000
-2.6%
0.01%
+12.5%
Q2 2018$1,197,000
+71.0%
92,400
+117.9%
0.01%
+60.0%
Q1 2018$700,00042,4000.01%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 12,201,261$203,150,0004.07%
Paradigm Biocapital Advisors LP 907,428$15,109,0004.00%
Avoro Capital Advisors LLC 9,125,000$151,931,0002.77%
Logos Global Management LP 1,000,000$16,650,0002.16%
Avidity Partners Management LP 6,043,219$100,620,0002.10%
Orbimed Advisors 6,633,006$110,440,0001.79%
Parametrica Management Ltd 134,679$2,240,0001.66%
Boxer Capital, LLC 1,935,133$32,220,0001.66%
Fairmount Funds Management LLC 389,588$6,487,0001.53%
Long Focus Capital Management, LLC 705,000$11,738,0001.51%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders